Biotecnología
Biotecnología
Orna Therapeutics Acquires ReNAgade Therapeutics
27/05/2024 -
Will combine its circular RNA expression technology with ReNAgade's portfolio of LNP-based RNA delivery systems and editing programs.
Johnson & Johnson Agrees to Acquire Proteologix
27/05/2024 -
Will integrate Proteologix’s bispecific antibodies into its pipeline.
NEOsphere, Kymera Therapeutics Collaborate on Novel Molecular Glue Target Discovery
16/05/2024 -
Aim to create opportunities to target previously undruggable disease-causing proteins.
TriLink Invests in New RNA Innovation Center at Johns Hopkins
14/05/2024 -
Will accelerate transformational research in RNA therapeutics and discovery.
Ingenza Secures Innovation Funding to Expand codABLE Gene Design Algorithm
06/05/2024 -
Will adapt its machine learning platform to precisely control recombinant protein expression in Pichia pastoris.
Abzena Introduces Enhanced Bioassay Platform
02/05/2024 -
EpiScreen 2.0 predicts and evaluates potential risks of preclinical immunogenicity in protein, antibody and gene therapy therapeutics.
Fujifilm & Predictive Oncology Tackle Protein Interference
02/05/2024 -
Enter a collaboration and co-marketing agreement to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products.
MiLaboratories, Miltenyi Biotec Enter Genomics Alliance
02/05/2024 -
Combines MiLaboratories' RNA kit technology for immune sequencing with Miltenyi Biotec's production and commercialization capabilities.
Ipsen and Skyhawk Therapeutics Collaborate on RNA Targeting Research
25/04/2024 -
Aim to discover and develop small molecules for the treatment of rare neurological diseases.
Charles River & Axovia Partner to Support Development of Gene Therapies for Ciliopathies
10/04/2024 -
Axovia will leverage Charles River’s plasmid platform and expertise in plasmid DNA production to accelerate time to clinic.
Ship of Theseus Taps Charles River as Manufacturing Partner
08/04/2024 -
Charles River to support the development of novel HOX-based therapies through plasmid DNA manufacturing.
Lonza Expands Spray-Drying Services for Protein-Based Inhaled Therapies
03/04/2024 -
New offering provides clinical and commercial manufacturing services at a kilogram scale from Lonza’s Bend (US) site.
Exothera Launches Nucleic Acids Service Offering Powered by Ntensify
27/03/2024 -
Continuous batch production of RNA service significantly cuts clinical development time while enhancing quality and yield.
Samsung Life Science Fund Invests in BrickBio
24/03/2024 -
Samsung affiliates will work with BrickBio to evaluate, manufacture, and develop therapies using BrickBio's protein engineering technology.
BostonGene Named Akoya Biosciences' Qualified CRO
24/03/2024 -
Will offer end-to-end spatial biology solutions to life sciences researchers for advanced spatial proteomics analysis.
ProteoNic Biosciences Partners with Ginkgo Bioworks to Support Clients
15/03/2024 -
Grants Ginkgo Bioworks’ customers access to ProteoNic's vector technology.
Key Proteo to Build New CLIA-Certified Lab
11/03/2024 -
Aims to expand its scope of operations to serve unaddressed newborn screening needs.
Polyplus Receives GMP Certification for Recombinant Protein & DNA Production
07/03/2024 -
Also adds an additional GMP clean room for the production of GMP cell banks.
Evaluating New Approaches to Developing AIDS Vaccines by Creating Virus-like Particles that Display HIV Antigens or by Using Live, Attenuated (Weakened), non-HIV Viruses to Express HIV Proteins
07/03/2024 -
A description of Ira Berkower's research program and related publications.
New Ways to Predict How Well Vaccines Protect Against Tuberculosis, Tularemia and Other Bacteria That Live Inside Cells
07/03/2024 -
A description of Karen Elkins's research program and related publications.
Ginkgo Bioworks Acquires Patch Biosciences
29/02/2024 -
Strengthens its Gene Therapy Services, Cell Therapy Services, and RNA Therapeutics Services.